Dupilumab trials for Atopic Dermatitis

All Dupilumab trials · All Atopic Dermatitis trials

Phase breakdown

Recruiting trials studying Dupilumab for Atopic Dermatitis

• A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis
  NCT07399067 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
  NCT06461897 · Phase: Phase 3 · Ages: 2 Years to 11 Years · Sex: All (male and female) · 150 locations
• A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis
  NCT07330934 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions Respond to Dupilumab Treatment
  NCT06192563 · Phase: Not specified · Ages: 6 Months to 17 Years · Sex: All (male and female) · 9 locations
• An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
  NCT03936335 · Phase: Not specified · Ages: 18 Years to 49 Years · Sex: Female · 1 location
• DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema
  NCT06004986 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Ethnic Differences in Mechanisms of Action of Dupilumab
  NCT05268107 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Mind and Skin - the Neurocutaneous Axis in Atopic Eczema
  NCT05790330 · Phase: Not specified · Ages: 12 Years to 18 Years · Sex: All (male and female) · 1 location
• Molecular Signatures in Inflammatory Skin Disease
  NCT03358693 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 2 locations
• Molecular Signatures of Cutaneous Dupilumab Response
  NCT05858619 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Replication of the Heads Up Atopic Dermatitis Trial With Registry Data
  NCT06937788 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis
  NCT07467564 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female) · 7 locations
• Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
  NCT05042258 · Phase: Phase 4 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Dupilumab for Atopic Dermatitis?

13 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.